Apoptosis
Clonogenic tumor growth inhibited by Smac
Published in Cancer Vaccine Week, January 9th, 2006
"While Smac has been described to sensitize for apoptosis, its effect on cell viability in the absence of apoptotic stimuli has remained unclear. Here, we report that Smac inhibits clonogenic tumor growth by blocking random migration and proliferation and by enhancing apoptosis in a cell density and cell type dependent manner in SH-EP neuroblastoma cells," investigators in Germany reported.
"Inhibition of clonogenic survival by overexpression of full-length or processed Smac strictly depended on low cell density, and was reversible by replatement at high...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Vaccine Week
Source: Cancer Vaccine Week (2006-01-09)
More Articles from Cancer Vaccine Week
- Cancer Vaccine
Tumor cell-pulsed dendritic cells and activated lymphocytes prolong survival - Human Papillomavirus Vaccine
CD8+ T cells from DNA vaccine control tumors through Fas-FasL pathway - Human Papillomavirus Vaccine
Study characterized HPV-16 E6 DNA vaccines employing intercellular spreading strategies - Melanoma Vaccine
Marked differences found in melanoma antigen-specific T cell responsiveness - Thyroid Cancer Vaccine
Autologous tumor cell lines have been developed for dendritic cell vaccination - Apoptosis
Ircinin-1 induced apoptosis in human melanoma cells - More from this issue of Cancer Vaccine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
